Entity

Time filter

Source Type

Matsudo, Japan

Trademark
Genetein Co. | Date: 2009-11-24

Chemicals for use in biochemical industry, namely, chemicals and reagents for separating, extracting, purifying, synthesizing, producing and amplifying for cells, bacteria, virus, DNA, RNA, oligo-nucleotide, proteins, carbohydrates, sugar chain, peptide and other biochemical or biological substances, not for medical and veterinary use; chemical carriers, namely, chemicals for use in the biotechnology industry having biochemical and biological substances bonded therewith for analysis of biochemical and biological substances such as DNA, RNA, oligo-nucleotides, proteins, carbohydrates, sugar chain, peptides, not for medical or veterinary use; kit comprised of chemical carriers, namely, chemicals for use in the biotechnology industry having biochemical and biological substances bonded herewith for analysis of biochemical and biological substances such as DNA, RNA, oligo-nucleotides, proteins, carbohydrates, sugar chain, peptides, not for medical or veterinary use; plant growth regulating preparations; chemicals for use in agriculture, except fungicides, weedkillers, herbicides, insecticides and parasiticids, namely, chemicals for separating, extracting, purifying, synthesizing, producing and amplifying cells, bacteria, virus, DNA, RNA, oligo-nucleotide, proteins, carbohydrates, sugar chain, peptide and other biochemical or biological substances; fertilizers; artificial sweeteners. Pharmaceutical, veterinary and sanitary preparations for diagnostics and analysis, namely, reagents for pharmaceutical diagnostics by use of DNA, RNA, oligo-nucleotide, proteins, carbohydrates, sugar chain, peptide, or other biochemical or biological substances; Chemical carriers, namely, chemical reagents for medical diagnostic purposes having biochemical and biological substances bonded therewith for analysis of biochemical and biological substances such as DNA, RNA, oligo-nucleotides, proteins, carbohydrates, sugar chain, peptide, in clinical medicine and clinical medical procedures; Kit comprised of chemical carriers, namely, chemical reagents for medical purposes having biochemical and biological substances bonded therewith for analysis of biochemical and biological substances, in clinical medicine and clinical medical procedures. Pipette for laboratory use; pipette tips for laboratory use; capillary tubes for laboratory use; test tubes for laboratory use; microtubes, namely, micro test tubes for laboratory use; petri dishes for laboratory use; vials for laboratory use; culture bottles and trays for laboratory use; laboratory glassware, namely, flasks and flask holders; seals, namely, laboratory equipment in the nature of seals for laboratory bottles; reagent reservoirs for dispensing reagents for laboratory use; syringes, namely, laboratory syringes; graduated dispensers, namely, graduated dispensers to dispense fluids for laboratory use; and solid and liquid waste receptacles, all for use in the analysis, testing, and research of biochemical and biological substances such as DNA, RNA, oligo-nucleotides, proteins, sugar chain, carbohydrates, peptides; measuring and testing machines and instruments for analysis of biochemical and biological substances, namely, genetic analyzers, fragment analyzers, electrophoresis machines not for medical purposes, linkage analyzers, namely, genetic linkage analysis instruments and software sold as a unit for molecular diagnostic purposes, genetic mappers, organic and inorganic synthesizers, namely, synthesizers for use in screening and optimizing chemical reactions for laboratory purposes, spectrophotometers, meters for measuring luminescence absorbency, fluorescence, and time-resolved fluorescence, namely, microplate readers, fluorescent scanners, thermometers, not for medical use, chronographs for use as specialized time recording apparatus, robotic workstations comprised of laboratory robots, computers, and computer monitors, incubators, immunoassay analyzers, namely, automated immunoassay analyzers; and sample preparation and screening workstations comprised of containers for biological substances and liquid magnetic particle suspensions for use in purifying proteins, and distributors for applying and removing magnetic beads bound to proteins; electronic machines, apparatus, and their parts, namely, central processing units, computer hardware, and computer software, all used in the testing, analysis, and examination of DNA, RNA, oligo-nucleotides, proteins, sugar chain, carbohydrates, and peptides; electrolysers; and electrolytic cells. Medical machines and apparatus for examining and studying biochemical and biological substances extracted from patients, namely, urine testing devices, namely, protein testing devices, saliva testing devices, stool testing devices, immune substances analyzers, DNA diagnosis devices, electrophoreses, doping test devices. Testing, inspection or research of pharmaceuticals, cosmetics or foodstuff; testing or research on machines, apparatus and instruments.


Akai H.,Yurtec Corporation | Tochihara Y.,Kyushu University | Ishimatsu S.,University of Occupational and Environmental Health Japan | Kusakari H.,Yurtec Corporation | And 4 more authors.
Journal of Environmental Engineering | Year: 2010

There are increasing reports of the evidence of Legionellosis. More rapid inspection of Legionella is necessary for minimizing damage to civilians. In this respect, on-site inspection method is required. This report provides the new method which can achieve on-site inspection of Legionella in water by combining the capture beads concentration and immunochromatography detection. In the concentration method, the beads which capture Legionella is used, and large volume sample (over 10 L) is treated by peristaltic pump. Beads concentration method can be also applicable for culture method and detection by polymerase chain reaction (PCR). The new method provides the practical solution for on-site legionella inspection. Source


Mitarai S.,Research Institute of Tuberculosis | Karinaga R.,Genetein Co. | Karinaga R.,Precision System Science Co. | Yamada H.,Research Institute of Tuberculosis | And 6 more authors.
Journal of Microbiological Methods | Year: 2012

Centrifugation is a necessary concentrating step for the detection of Mycobacterium tuberculosis in a liquid culture. However, centrifugation is biologically hazardous and presents an obstacle in the development of an automated culture system. A bead-based bacterial concentration method, TRICORE, was recently developed by Genetein Co., Ltd. We compared the efficacy of TRICORE and conventional centrifugation for concentrating M. tuberculosis in clinical sputum specimens by using liquid and solid culture systems. Among 90 pretreated clinical sputum specimens, 51 (57.3%) and 55 (61.8%) M. tuberculosis isolates were recovered by the MGIT culture system by using the centrifugation and TRICORE methods, respectively (chi-square test, p=. 0.5413). The detection time for the centrifugation method was 359.3 ± 117.0. h, while that for the bead-based concentration method was 377.6 ± 162.3. h (p=. 0.5637). However, the number of colonies recovered on solid media were significantly higher with the TRICORE method (p=. 0.003). In particular, among the smear-negative specimens, culture positivity of the TRICORE method was 39.6%, while that of the centrifugation method was 15.1%. The TRICORE bead-based concentration method was considered equivalent to centrifugation and enabled efficient collection of paucibacillary specimens in solution. Thus, the new noncentrifugation concentration method could yield more positive culture results. © 2012 Elsevier B.V.. Source

Discover hidden collaborations